Modivcare to Report Fourth Quarter and Full Year 2024 Financial Results and Adjourn Special Meeting to Follow Report

Modivcare Inc. (NASDAQ: MODV), a technology-enabled healthcare services company, has announced that it will release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025, after market close. The company will host a conference call at 5:00 p.m. Eastern Time on the same day. Additionally, Modivcare plans to postpone its previously announced special stockholders meeting from March 3, 2025, to March 13, 2025, at 10:00 a.m. Mountain Time. This adjournment will allow for the release of Q4 and full year 2024 financial results before the special meeting.

The release of Q4 and full year 2024 financial results will provide valuable insights into Modivcare's performance during the period. Investors and analysts will be closely watching the company's revenue and adjusted EBITDA, as well as the performance of its segments (NEMT, PCS, and RPM). The financial results will also offer updates on working capital and cash flow, which can impact the Company's liquidity and growth prospects.

The adjournment of the special meeting has strategic implications for Modivcare's long-term plans and shareholder value. By postponing the meeting, the company ensures that its financial results are released before the special meeting takes place, allowing shareholders to make more informed decisions about the company's future direction and the proposed matters to be considered at the special meeting. The adjournment also provides Modivcare with additional time to communicate its financial performance and strategic initiatives to shareholders, which can help build confidence in the company's long-term plans and potential for shareholder value creation.

In conclusion, the release of Q4 and full year 2024 financial results and the adjournment of the special meeting are significant developments for Modivcare. The financial results will provide valuable insights into the company's performance, while the adjournment of the special meeting has strategic implications for Modivcare's long-term plans and shareholder value. Investors and analysts will be closely watching these developments as they assess the company's future growth prospects and potential for shareholder value creation.